Production and purification of an analog of glucagon-like peptide-1 by auto-induction and on-column cleavage in Escherichia coli

World Journal of Microbiology and Biotechnology

Volumn 26, Issue 9, 2010, Pages 1675-1682

  Gao, Mingming ^a   Ma, Chen ^a   Liu, Wenchao ^a   Zhu, Jing ^a   Tian, Hong ^a   Gao, Xiangdong ^a   Yao, Wenbing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Auto induction; Expression and purification; Glucagon like peptide 1; On column cleavage

Indexed keywords

AUTO-INDUCTION; BACTERIAL CELLS; DOSE-DEPENDENT; EXPRESSION AND PURIFICATION; FUSION PROTEINS; INDUCTION SYSTEM;

BACTERIOLOGY; CELL CULTURE; CENTRIFUGATION; ESCHERICHIA COLI; GEL PERMEATION CHROMATOGRAPHY; GLUCOSE; PEPTIDES;

PURIFICATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 77955269975     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-010-0345-3     Document Type: Article

References (22)

1. Choi SI, Song HW, Moon JW, Seong BL (2001) Recombinant enterokinase light chain with affinity tag: expression from Saccharomyces cerevisiae and its utilities in fusion protein technology. Biotechnol Bioeng 75: 718-724. doi: 10. 1002/bit. 10082.
2. Corsini L, Hothorn M, Scheffzek K, Sattler M, Stier G (2008) Thioredoxin as a fusion tag for carrier-driven crystallization. Protein Sci 17: 2070-2079. doi: 10. 1110/ps. 037564. 108.
3. Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ (1998) Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 41: 271-278. doi: 10. 1007/s001250050903.
4. Doyle ME, Egan JM (2007) Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 113: 546-593. doi: 10. 1016/j. pharmthera. 2006. 11. 007.
5. Drucker DJ (1998) Glucagon-like peptides. Diabetes 47: 159-169. doi: 10. 2337/diabetes. 47. 2. 159.
6. Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368: 1696-1705. doi: 10. 1016/S0140-6736(06)69705-5.
7. Esipov RS, Stepanenko VN, Gurevich AI, Chupova LA, Miroshnikov AI (2006) Production and purification of recombinant human glucagon overexpressed as intein fusion protein in Escherichia coli. Protein Pept Lett 13: 343-347. doi: 10. 2174/092986606775974320.
8. Esposito D, Chatterjee DK (2006) Enhancement of soluble protein expression through the use of fusion tags. Curr Opin Biotechnol 17: 353-358. doi: 10. 1016/j. copbio. 2006. 06. 003.
9. Gasparian ME, Ostapchenko VG, Dolgikh DA, Kirpichnikov MP (2006) Biochemical characterization of human enteropeptidase light chain. Biochemistry (Mosc) 71: 113-119. doi: 10. 1134/S0006297906020015.
10. Gasparian ME, Ostapchenko VG, Yagolovich AV, Tsygannik IN, Chernyak BV, Dolgikh DA, Kirpichnikov MP (2007) Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase. Biotechnol Lett 29: 1567-1573. doi: 10. 1007/s10529-007-9446-y.
11. 4Lys on enterokinase cleavage of a fusion protein. Anal Biochem 269: 10-16. doi: 10. 1006/abio. 1998. 3084.
12. Liew OW, Ching Chong JP, Yandle TG, Brennan SO (2005) Preparation of recombinant thioredoxin fused N-terminal proCNP: analysis of enterokinase cleavage products reveals new enterokinase cleavage sites. Protein Expr Purif 41: 332-340. doi: 10. 1016/j. pep. 2005. 03. 006.
13. Liew OW, Jenny Chong PC, Lim YZ, Ang CX, Amy Lau YC, Yandle TG, Brennan SO (2007) An SRLLR motif downstream of the scissile bond enhances enterokinase cleavage efficiency. Biochimie 89: 21-29. doi: 10. 1016/j. biochi. 2006. 10. 005.
14. Nielsen LL (2005) Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes. Drug Discov Today 10: 703-710. doi: 10. 1016/S1359-6446(05)03460-4.
15. Schägger H (2006) Tricine-SDS-PAGE. Nat Protoc 1: 16-22. doi: 10. 1038/nprot. 2006. 4.
16. Shahravan SH, Qu X, Chan IS, Shin JA (2008) Enhancing the specificity of the enterokinase cleavage reaction to promote efficient cleavage of a fusion tag. Protein Expr Purif 59: 314-319. doi: 10. 1016/j. pep. 2008. 02. 015.
17. Studier FW (2005) Protein production by auto-induction in high density shaking cultures. Protein Expr Purif 41: 207-234. doi: 10. 1016/j. pep. 2005. 01. 016.
18. Suh CW, Park SH, Park SG, Lee EK (2005) Covalent immobilization and solid-phase refolding of enterokinase for fusion protein cleavage. Process Biochem 40: 1755-1762. doi: 10. 1016/j. procbio. 2004. 06. 050.
19. Wang Y, Jiang Y, Gong T, Cui X, Li W, Feng Y, Wang B, Jiang Z, Li M (2009) High-level expression and novel antifungal activity of mouse beta defensin-1 mature peptide in Escherichia coli. Appl Biochem Biotechnol 160(1): 213-221. doi: 10. 1007/s12010-009-8566-3.
20. Yuan LD, Hua ZC (2002) Expression, purification, and characterization of a biologically active bovine enterokinase catalytic subunit in Escherichia coli. Protein Expr Purif 25: 300-304. doi: 10. 1016/S1046-5928(02)00012-8.
21. Zhang L, Yu H, Song C, Lin X, Chen B, Tan C, Cao G, Wang Z (2009) Expression, purification, and characterization of recombinant human β-amyloid42 peptide in Escherichia coli. Protein Expr Purif 64: 55-62. doi: 10. 1016/j. pep. 2008. 10. 007.
22. Zhou J, Chu J, Wang YH, Wang H, Zhuang YP, Zhang SL (2008) Purification and bioactivity of exendin-4, a peptide analogue of GLP-1, expressed in Pichia pastoris. Biotechnol Lett 30: 651-656. doi: 10. 1007/s10529-007-9610-4.